HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China · Delayed Price · Currency is CNY 9.68
+0.04 (0.41%)
Apr 29, 2026, 3:00 PM CST
SHA:600829 Revenue
HPGC Renmintongtai Pharmaceutical had revenue of 2.82B CNY in the quarter ending March 31, 2026, with 5.89% growth. This brings the company's revenue in the last twelve months to 10.54B, up 4.14% year-over-year. In the year 2025, HPGC Renmintongtai Pharmaceutical had annual revenue of 10.38B with 3.29% growth.
Revenue (ttm)
10.54B
Revenue Growth
+4.14%
P/S Ratio
0.53
Revenue / Employee
3.67M
Employees
2,870
Market Cap
5.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.38B | 330.43M | 3.29% |
| Dec 31, 2024 | 10.05B | -341.70M | -3.29% |
| Dec 31, 2023 | 10.39B | 748.89M | 7.77% |
| Dec 31, 2022 | 9.64B | 325.86M | 3.50% |
| Dec 31, 2021 | 9.32B | 1.31B | 16.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition